Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma

SIMPLE SUMMARY: The incidence of cholangiocarcinomas is rising. The prognosis of this heterogeneous group of tumors remains poor. Standard chemotherapy options are limited and frequently not effective. Recently, extensive molecular profiling identified key actionable drivers leading to successful bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fostea, Raluca Maria, Fontana, Elisa, Torga, Gonzalo, Arkenau, Hendrik-Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565778/
https://www.ncbi.nlm.nih.gov/pubmed/32932925
http://dx.doi.org/10.3390/cancers12092599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565778/
https://www.ncbi.nlm.nih.gov/pubmed/32932925
http://dx.doi.org/10.3390/cancers12092599

Ejemplares similares